CD11c
Overview
CD11c (encoded by ITGAX) is an alpha integrin primarily expressed on dendritic cells and monocytes. On B cells, high CD11c surface expression marks extrafollicular plasmablasts, age-associated B cells (ABCs), and the DN2 B cell subset. CD11c is one of the defining markers of the DN2 phenotype (IgD⁻CD27⁻CXCR5⁻CD21⁻CD11c⁺) and is used to discriminate DN2 from DN1 cells.
Key Points from Literature
-
DN2 cells are CD11c bright: CD11c is highly expressed on DN2 cells and aNAV cells but low/absent on DN1, SWM, and rNAV. CD11c expression validated at both RNA (ITGAX) and protein level, with complete concordance (see Jenks2018 - DN2 B Cells and EF Pathway in SLE, RNA-seq + flow cytometry).
-
Gating utility: CXCR5 vs. CD11c dot plots on IgD⁻CD27⁻ cells cleanly separate DN1 (CXCR5⁺CD11c^lo) from DN2 (CXCR5⁻CD11c^hi). CD21 vs. CD11c provides equivalent discrimination (see Jenks2018 - DN2 B Cells and EF Pathway in SLE).
-
Shared with aNAV cells: aNAV cells (IgD⁺CD27⁻CXCR5⁻) are also CD11c bright — CD11c expression links these two populations phenotypically and transcriptionally (see Jenks2018 - DN2 B Cells and EF Pathway in SLE).
-
Murine parallel: Murine CD11c^bright ABCs are T-bet-dependent and important for anti-viral IgG2a responses and autoimmunity. Human DN2 cells share this CD11c^bright T-bet⁺ phenotype (see Jenks2018 - DN2 B Cells and EF Pathway in SLE, citing Rubtsova et al. 2015).
-
In vitro-generated DN2 cells upregulate CD11c: rNAV cells stimulated with TLR7 + IFN-γ + IL-21 upregulate CD11c as they differentiate into aNAV and DN2 cells, confirming that CD11c acquisition is part of the EF differentiation programme (see Jenks2018 - DN2 B Cells and EF Pathway in SLE).
-
CD11c is heterogeneous across B cell compartments: CD11c expression is not confined to DN2 cells — it is found on aNAV cells (highest), DN2, and at lower levels on a subset of CD27⁺ switched memory cells (activated ABC memory, both resting CD21⁺ and activated CD21lo fractions). Using CD11c alone to identify “ABC” or “AtB” therefore captures a heterogeneous mix of populations with different origins and functions (see Sanz2025 - Human Atypical B Cells Overview, review, Table 1 and Figure 2).
-
CD11c can be induced without T-bet or IFN-γ: CD11c and other ABC markers can be upregulated in vitro through diverse activation conditions in the absence of IFN-γ stimulation or T-bet expression. CD11c is therefore not a reliable proxy for T-bet⁺ identity (see Sanz2025 - Human Atypical B Cells Overview, review).
-
T-bet/FcRL5 can substitute for CD11c in gating: CXCR5 vs. CD11c, CXCR5 vs. T-bet, and CXCR5 vs. FcRL5 staining identify similar populations, providing practical flexibility for panel design (see Sanz2025 - Human Atypical B Cells Overview, review, Figure 2C).
-
CD11c expression validated in acute viral infection: In COVID-19, intracellular staining (n=4 ICU patients) confirmed that aN and DN2 cells had the highest T-bet and CD11c expression of any B cell population, above rN, DN1, and DN3. CD11c expression on UMAP projections cleanly demarcated the aN/DN2 region (ROI 1) that distinguished ICU from outpatient and healthy B cell profiles (see Woodruff2020 - EF B Cell Responses in COVID-19, spectral FCM + intracellular staining).
-
CD11c used in DN1/DN2/DN3 gating in 24-marker panel: The Woodruff2020 Table 1 gating scheme uses CD11c vs. CD21 within the DN gate to resolve DN1 (CD11c⁻CD21⁺), DN2 (CD11c⁺CD21⁻), and DN3 (CD11c⁻CD21⁻). This is the standardised gating applicable to spectral panels for EF pathway studies (see Woodruff2020 - EF B Cell Responses in COVID-19, Table 1).
-
CD11c⁺ marks EF B cells in acute dengue: CD21⁻CD11c⁺ B cells within the IgD⁻CD27⁻ (DN) gate are significantly expanded during acute dengue infection. This is the first demonstration of CD11c⁺ EF-phenotype B cells in dengue, validating the SLE/COVID-19 DN2 phenotype in a third disease context. CD11c was used alongside CD21 to identify EF B cells without CXCR5 staining (see Ansari2025 - Peripheral T Helper Subset Drives B Cell Response in Dengue, multi-color FCM, n=170 acute dengue).
Contradictions & Debates
None documented in current wiki sources.
Related Pages
DN2 B Cell, Activated Naive B Cell, T-bet, CXCR5, Double-Negative B Cell, Extrafollicular Response, FCRL5, CXCR3, CD21, Peripheral Helper T Cell